Update to living systematic review on drug treatments for covid-19

Update includes data (low certainty evidence) on ACE inhibitors, anakinra, full dose anticoagulation, ivermectin, ivermectin plus doxycycline, JAK inhibitors, lopinavir-ritonavir plus interferon-beta, peginterferon lambda, proxalutamide, sulodexide, vitamin C, and vitamin D.

British Medical Journal